NeuroSense Therapeutics Ltd (NASDAQ:NRSN)’s traded shares stood at 0.38 million during the last session, with the company’s beta value hitting 1.67.The NRSN share’s 52-week high
In the last trading session, 1.11 million NeuroSense Therapeutics Ltd (NASDAQ:NRSN) shares changed hands as the company’s beta touched 1.61. With the company’s per share
NeuroSense Therapeutics Ltd (NASDAQ:NRSN)’s traded shares stood at 0.3 million during the last session, with the company’s beta value hitting 1.52. At the close of
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne